Francesca Lorenzin

1.7k citations
14 papers · 1.1k · 1 hit paper · h-index 9

Impact in

Papers in

    • CRISPR and Genetic Engineering 5
    • Genomics and Chromatin Dynamics 2
    • RNA Research and Splicing 2
    • RNA modifications and cancer 2
    • Advanced biosensing and bioanalysis techniques 1
    • Cancer Genomics and Diagnostics 3

Francesca Lorenzin

14 papers receiving 1.1k citations

Francesca Lorenzin's Hit Papers

A highly specific SpCas9 variant is identified by in vivo screening in yeast 2018 · 367 citations
3670+2+5Years since publication100200300

Peers

Francesca Lorenzin
Comparison fields: 5 of 71
  • Business and International Management 65
  • Aging 42
  • Molecular Biology 976
  • Cancer Research 109
  • Oncology 160
Replace Danilo Maddalo with:
Danilo Maddalo Germany
Joaquín Custodio Sweden
Megha Chandrashekhar Canada
Patricia Mero Canada
Joseph P. Milazzo United States
Angelo Amabile United States
Giuseppe Leuzzi United States
Anh Leith United States
Kasey Jividen United States
Joost Schimmel Netherlands
Francesca Lorenzin relative to Danilo Maddalo Germany Danilo Maddalo's profile →
Citations per field
00.5×
Danilo Maddalo · 1×
Citations per year

Countries citing papers authored by Francesca Lorenzin

Since Specialization
Citations

This map shows the geographic impact of Francesca Lorenzin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Lorenzin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Lorenzin more than expected).

Fields of papers citing papers by Francesca Lorenzin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Lorenzin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Lorenzin. The network helps show where Francesca Lorenzin may publish in the future.

Co-authors

The 25 scholars most cited alongside Francesca Lorenzin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Francesca Lorenzin Line = papers co-authored together Francesca Lorenzin links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
A highly specific SpCas9 variant is identified by in vivo screening in yeast
Hit paper breakdown →
2018367
2 2014348
3 2018132
4 2016111
5 201771
6 201532
7 202118
8 202218
9 198418
10 20215
11
[Pseudo-hyperaldosteronism caused by licorice. Pathogenetic considerations and presentation of a clinical case].
19903
12 20193
13 20242
14 20212

About Francesca Lorenzin

Francesca Lorenzin is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (5 papers), Cancer Genomics and Diagnostics (3 papers), Genomics and Chromatin Dynamics (2 papers), PARP inhibition in cancer therapy (2 papers), RNA Research and Splicing (2 papers), Prostate Cancer Treatment and Research (2 papers), RNA modifications and cancer (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Business and International Management (65 citations), Aging (42 citations), Molecular Biology (976 citations), Cancer Research (109 citations) and Oncology (160 citations). Francesca Lorenzin has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Francesca Demichelis, Elmar Wolf, Davide Prandi, Gianluca Petris, Antonio Casini, Alessandro Romanel, Anna Cereseto, Claudia Montagna, Martin Eilers and Alberto Inga. Their work appears in journals such as Cancers, Computational and Structural Biotechnology Journal, Nature Communications, The Plant Cell and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact